President Donald Trump speaks at a Nov. 20 news conference in the briefing room at the White House (Susan Walsh/AP)

A Covid-19 vac­cine OK is im­mi­nent, but Trump con­tin­ues un­prece­dent­ed as­sault on the FDA

The FDA is ex­pect­ed to au­tho­rize Pfiz­er and BioN­Tech’s Covid-19 vac­cine can­di­date im­mi­nent­ly, but Pres­i­dent Don­ald Trump is nev­er­the­less ratch­et­ing up pres­sure on the agency …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.